benzoxazoles has been researched along with Cirrhosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chalmers, JD; Fernandez, C; Mange, KC; Rubino, CM; Teper, A; Usansky, H; Zou, J | 1 |
| Bucala, R; Chen, D; Fu, Q; Huang, H; Leng, L; Li, J; Lu, L; Pu, J; Ye, S; Yuan, A | 1 |
| Akagah, B; Bernadat, G; Fadel, E; Guignabert, C; Huertas, A; Humbert, M; Jalce, G; Le Hiress, M; Phan, C; Simonneau, G; Thuillet, R; Tu, L | 1 |
| Aarts, J; Berthet, K; Damy, T; Judge, DP; Kristen, AV; Li, H | 1 |
2 trial(s) available for benzoxazoles and Cirrhosis
| Article | Year |
|---|---|
Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis Bronchiectasis.
Topics: Adult; Benzoxazoles; Bronchiectasis; Cathepsin G; Cystic Fibrosis; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Fibrosis; Humans; Leukocyte Elastase; Myeloblastin; Oxazepines; Serine Proteases | 2022 |
Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis.
Topics: Adult; Aged; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Europe; Female; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Humans; Male; Middle Aged; Mutation; Myocardium; Phenotype; Prealbumin; Risk Factors; Time Factors; Treatment Outcome; United States | 2015 |
2 other study(ies) available for benzoxazoles and Cirrhosis
| Article | Year |
|---|---|
The small molecule macrophage migration inhibitory factor antagonist MIF098, inhibits pulmonary hypertension associated with murine SLE.
Topics: Adult; Animals; Benzoxazoles; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Disease Models, Animal; Female; Fibrosis; Humans; Intramolecular Oxidoreductases; Lupus Erythematosus, Systemic; Macrophage Migration-Inhibitory Factors; Male; Mice, Inbred C57BL; Middle Aged; Mitogen-Activated Protein Kinases; Myocytes, Smooth Muscle; Pulmonary Arterial Hypertension; Pulmonary Artery | 2019 |
Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.
Topics: Animals; Antihypertensive Agents; Benzoxazoles; Cell Line; Cell Survival; Drug Design; Fibrosis; Hypertension, Pulmonary; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Male; MAP Kinase Signaling System; Models, Molecular; Molecular Docking Simulation; Rats; Rats, Wistar; Structure-Activity Relationship; Thiones | 2018 |